Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:2010-2017, doi:10.1016/S0735-1097(03)00405-4
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maisel, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maisel, A. S.

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction

Results from the Breathing Not Properly Multinational Study

Alan S. Maisel, MD, FACC*, James McCord, MD, Richard M. Nowak, MD, Judd E. Hollander, MD, Alan H. B. Wu, PhD, MD, MBA, Philippe Duc, MD, Torbjørn Omland, MD, PhD, Alan B. Storrow, MD, Padma Krishnaswamy, MD, William T. Abraham, MD, FACC, Paul Clopton, MS, Gabriel Steg, MD, Marie Claude Aumont, MD, Arne Westheim, MD, PhD, MPH, Cathrine Wold Knudsen, MD, Alberto Perez, MD, Richard Kamin, MD, Radmila Kazanegra, MD, Howard C. Herrmann, MD, FACC, Peter A. McCullough, MD, MPH, FACC Breathing Not Properly Multinational Study Investigators*



View larger version (29K):

[in a new window]
 
Figure 1 Box plots showing median levels of B-type natriuretic peptide (BNP) measured in the emergency department in patients with dyspnea not due to heart failure, in those with an adjudicated final diagnosis of non-systolic left ventricular dysfunction, and in those with systolic left ventricular dysfunction. CHF = congestive heart failure.

 


View larger version (35K):

[in a new window]
 
Figure 2 Number of patients in each New York Heart Association (NYHA) functional class with systolic versus non-systolic dysfunction.

 


View larger version (34K):

[in a new window]
 
Figure 3 Box plots showing median levels of B-type natriuretic peptide (BNP) measured in men and women over 70 years of age with dyspnea not due to heart failure, and those with an adjudicated final diagnosis of heart failure, subdivided by those with systolic congestive heart failure (CHF) and those with non-systolic CHF.

 


View larger version (28K):

[in a new window]
 
Figure 4 Receiver-operating characteristic curve for B-type natriuretic peptide (BNP) for differentiating between congestive heart failure (CHF) and non-CHF cases and between systolic versus non-systolic dysfunction (non-CHF patients excluded). Tables show decision statistics at selected cut points. AUC = area under the curve.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement